Compare HQL & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HQL | CGC |
|---|---|---|
| Founded | 1992 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Investment Managers | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.5M | 404.3M |
| IPO Year | N/A | 2023 |
| Metric | HQL | CGC |
|---|---|---|
| Price | $17.19 | $1.06 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 105.4K | ★ 7.4M |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | ★ 11.56% | N/A |
| EPS Growth | N/A | ★ 36.75 |
| EPS | ★ 0.79 | N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | N/A | $8.04 |
| Revenue Next Year | N/A | $11.36 |
| P/E Ratio | $21.78 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.58 | $0.84 |
| 52 Week High | $17.80 | $2.38 |
| Indicator | HQL | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 54.34 |
| Support Level | $16.40 | $1.01 |
| Resistance Level | $17.40 | $1.25 |
| Average True Range (ATR) | 0.35 | 0.07 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 81.79 | 76.52 |
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.